Finance

Beta
Lists
4886:TYO
ASKA Pharmaceutical Holdings Co Ltd
¥2,761.00
+1.62%
(+44.00) 1D
Jun 2, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4886...
Open
¥2,667
High
¥2,775
Low
¥2,610
Mkt. cap
79.42B
Avg. vol.
130.77K
Volume
140.80K
Dividend
2.17%
Quarterly dividend
¥15
Ex-dividend date
Sep 29, 2025
P/E ratio
14.45
52-wk high
¥3,045
52-wk low
¥1,920
EPS
¥191
No. of employees
2K
Open
¥2,667
High
¥2,775
Low
¥2,610
Mkt. cap
79.42B
Avg. vol.
130.77K
Volume
140.80K
Dividend
2.17%
Quarterly dividend
¥15
Ex-dividend date
Sep 29, 2025
P/E ratio
14.45
52-wk high
¥3,045
52-wk low
¥1,920
EPS
¥191
No. of employees
2K
News stories
From sources across the web
About ASKA Pharmaceutical Holdings Co Ltd
CEO-
Employees1.63K
FoundedApr 1, 2021
Headquarters-
SectorPharmaceutical industry
Websiteaska-pharma-hd.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
19.32B
15.93B
19.23B
16.64B
Cost of goods sold
10.69B
7.58B
9.89B
8.82B
Cost of revenue
10.69B
7.58B
9.89B
8.82B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.15B
7.18B
7.08B
6.90B
Operating expense
7.15B
7.18B
7.08B
6.90B
Total operating expenses
17.84B
14.76B
16.97B
15.72B
Operating income
1.48B
1.17B
2.26B
922.00M
Other non operating income
1.00M
83.00M
-24.00M
54.00M
EBT including unusual items
1.72B
1.04B
2.19B
2.04B
EBT excluding unusual items
1.62B
1.11B
2.12B
811.00M
Income tax expense
372.00M
2.00M
546.00M
445.00M
Effective tax rate
21.69%
0.19%
24.90%
21.80%
Other operating expenses
-
-
-
-
Net income
1.24B
982.00M
1.68B
1.52B
Net profit margin
6.44%
6.16%
8.72%
9.13%
Earnings per share
-
-
-
-
Interest and investment income
227.00M
-
164.00M
30.00M
Interest expense
-51.00M
-88.00M
-53.00M
-60.00M
Net interest expenses
176.00M
-88.00M
111.00M
-30.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
1.89B
-
1.69B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer